The AHA May 16 urged the Department of Commerce to consider tariff exceptions for critical minerals and derivative products used for medical purposes. Critical minerals have many medical uses, such as for magnetic resonance imaging, computerized tomography, positron emission tomography, radiopharmaceuticals and radiation therapy equipment.  
 
“Tariffs on critical minerals could have a particularly significant impact on complex medical devices that are higher cost and lower volume, in part due to requiring specialized parts and customization to meet the needs of health care providers,” the AHA wrote. “A recent survey found that 82% of health care experts expect tariff-related expenses to raise hospital costs by at least 15%, and 90% of supply chain professionals expect procurement disruptions. Given that hospital payments are set by government and private payer contracts, the costs would be borne by hospitals directly.” 

Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
A Health Affairs report published April 6 examined how changes in patient cost-sharing liability can impact hospital finances. The study found that…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to…
Headline
The Administration for Strategic Preparedness and Response March 24 announced an investment to expand the domestic manufacturing of propofol and metoprolol.…
Blog
Public
Recent analyses of national health spending have again placed hospitals at the center of the affordability debate. A recent Kaiser Family Foundation brief…